Human vaccines and immunotherapeutics: News April 2024.

IF 4.8 4区医学

Human Vaccines & Immunotherapeutics Pub Date : 2024-05-16 DOI:10.1080/21645515.2024.2354154

Ronald Ellis, Adam C Weiss

引用次数: 0

Abstract

2016-2018 Postdoctoral Fellowship, Behavioral Oncology, Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. 2016-2018 Postdoctoral Fellowship, Infection in Cancer Research, Center for Immunization and Infection Research in Cancer, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. 2011-2016 Doctor of Philosophy, Epidemiology (major), Social and Behavioral Science (minor), Indiana University, Indianapolis, IN. 2006-2010 Bachelor of Science, Biology (major), Psychology (minor), Spanish (minor), Purdue University, West Lafayette, IN.

查看原文本刊更多论文

人类疫苗和免疫疗法：2024 年 4 月的新闻。

2016-2018 博士后奖学金，行为肿瘤学，健康结果和行为系，H. Lee Moffitt 癌症中心和研究所，佛罗里达州坦帕市。2016-2018 博士后奖学金，佛罗里达州坦帕市 H. Lee Moffitt 癌症中心和研究所癌症免疫和感染研究中心，癌症研究中的感染。2011-2016 年美国印第安纳波利斯印第安纳大学流行病学（主修）、社会与行为科学（副修）哲学博士。2006-2010 年美国印第安纳州西拉法叶普渡大学，生物学（主修）、心理学（辅修）、西班牙语（辅修）理学士。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY

自引率

8.30%

发文量

审稿时长

1 months

期刊介绍： (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.